MML Investors Services
JNCE

MML Investors Services’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

MML Investors Services’s Portfolio JNCE Stock Details JNCE Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
2023
Q1 		$18K Hold
2022
Q4 		$11K Hold
2022
Q3 		$23K Hold
2022
Q2 		$30K Hold
2022
Q1 		$68K Hold
2021
Q4 		$84K Hold
2021
Q3 		$74K Hold
2021
Q2 		$68K Buy